What did Deutsche Bank do in the February 04, 2026 LLY analyst rating update?

Deutsche Bank maintained its **Buy** rating on Eli Lilly on February 04, 2026, citing market volatility and guidance as reasons for potential upside. No new price target was published in the StreetInsider-summary note.

Does the maintained Buy change the price target for LLY?

The Deutsche Bank note summarized by StreetInsider did not include a new price target, so the maintained Buy reflects confidence without an updated numeric target.

How should investors interpret this LLY analyst rating?

A maintained Buy signals analyst conviction that upside outweighs downside near term. Investors should weigh that view against the recent **-8.19% (-$89.54)** move and confirm with company guidance and financials.

What is Meyka AI’s view on LLY following this rating action?

Meyka AI rates LLY **B+**, accounting for benchmark performance, sector trends, growth metrics, and analyst consensus. This grade is informational and not investment advice.

Analyst Ratings

Deutsche Bank Maintains Buy for LLY (Eli Lilly and Company) Feb 2026

ByDanny Kontos February 5, 2026

Deutsche Bank maintained its Buy rating on Eli Lilly and Company (LLY) on February 04, 2026 at 12:35 PM, citing near-term volatility that could support a meaningful upside move. The note, summarized by StreetInsider, links recent market fear and Lilly’s guidance as reasons the stock can rebound, even as shares show a -8.19% (-$89.54) change since the firm’s prior comment. This LLY analyst rating keeps the street view constructive while stopping short of raising a price target in the published note.